The role of growth factors on acceleration of bone regeneration during distraction Osteogenesis

Tissue Engineering - Part B: Reviews

Volumn 19, Issue 5, 2013, Pages 442-453

  Makhdom, Asim M ^a,b   Hamdy, Reggie C ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENIC PROTEIN; DEVELOPMENT AND APPLICATIONS; DISTRACTION OSTEOGENESIS; FUTURE RESEARCH DIRECTIONS; PLATELET-DERIVED GROWTH FACTORS; TISSUE-ENGINEERING TECHNIQUES; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR;

TISSUE ENGINEERING;

BONE;

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; CALCIUM PHOSPHATE; CHORDIN; COLLAGEN; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; HETERODIMER; HOMODIMER; INSULIN GROWTH FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NANOPARTICLE; NOGGIN; OSTEOGENIC PROTEIN 1; OSTEOGENIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN E; DELAYED RELEASE FORMULATION; SIGNAL PEPTIDE;

ACCELERATION; ANGIOGENESIS; ANTIGENICITY; BIODEGRADABILITY; BONE DENSITY; BONE MARROW CELL; BONE MINERALIZATION; BONE REGENERATION; BONE REMODELING; BONE TURNOVER; CELL DIFFERENTIATION; CELL PROLIFERATION; DISTRACTION OSTEOGENESIS; FRACTURE HEALING; GENE TRANSFER; HUMAN; IMMUNOGENICITY; LATENT PERIOD; MESENCHYME CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; ANIMAL; CELL MOTION; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; PHARMACOLOGY; PROCEDURES;

ANIMALS; BONE REGENERATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; DELAYED-ACTION PREPARATIONS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OSTEOGENESIS, DISTRACTION; TISSUE ENGINEERING;

EID: 84883166454     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2012.0717     Document Type: Review

References (156)

1. Ai-Aql, Z.S., Alagl, A.S., Graves, D.T., Gerstenfeld, L.C., and Einhorn, T.A. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87, 107, 2008
2. Birch, J.G., and Samchukov, M.L. Use of the Ilizarov method to correct lower limb deformities in children and adolescents. J Am Acad Orthop Surg 12, 144, 2004
3. Eldridge, J.C., and Bell, D.F. Problems with substantial limb lengthening. Orthop Clin North Am 22, 625, 1991
4. Velazquez, R.J., Bell, D.F., Armstrong, P.F., Babyn, P., and Tibshirani, R. Complications of use of the Ilizarov technique in the correction of limb deformities in children. J Bone Joint Surg Am 75, 1148, 1993
5. Garcia-Cimbrelo, E., Olsen, B., Ruiz-Yague, M., Fernandez- Baillo, N., and Munuera-Marti'nez, L. Ilizarov technique. Results and difficulties. Clin Orthop Relat Res 283, 116, 1992
6. Ilizarov, G.A. The tension-stress effect on the genesis and growth of tissues. Part I. The influence of stability of fixation and soft-tissue preservation. Clin Orthop Relat Res 238, 249, 1989
7. Ilizarov, G.A. The tension-stress effect on the genesis and growth of tissues: Part I.I. The influence of the rate and frequency of distraction. Clin Orthop Relat Res 239, 263, 1989
8. Aronson, J., Good, B., Stewart, C., Harrison, B., and Harp, J. Preliminary studies of mineralization during distraction osteogenesis. Clin Orthop Relat Res 250, 43, 1990
9. Sato, M., Yasui, N., Nakase, T., Kawahata, H., Sugimoto, M., Hirota, S., Kitamura, Y., Nomura, S., and Ochi, T. Expression of bone matrix proteins mRNA during distraction osteogenesis. J Bone Miner Res 13, 1221, 1998
10. Rowe, N.M., Mehrara, B.J., Dudziak, M.E., Steinbrech, D.S., Mackool, R.J., Gittes, G.K., McCarthy, J.G., and Longaker, M.T. Rat mandibular distraction osteogenesis. Part I. Histologic and radiographic analysis. Plast Reconstr Surg 102, 2022, 1998
11. Mori, S., Akagi, M., Kikuyama, A., Yasuda, Y., and Hamanishi, C. Axial shortening during distraction osteogenesis leads to enhanced bone formation in a rabbit model through the HIF-1alpha/vascular endothelial growth factor system. J Orthop Res 24, 653, 2006
12. Gebauer, D., and Correll, J. Pulsed low intensity ultrasound: a new salvage procedure for delayed unions and nonunions after leg lengthening in children. J Pediatr Orthop 25, 750, 2005
13. Hou, W.W., Zhu, Z.L., Zhou, Y., Zhang, C.X., and Yu, H.Y. Involvement of Wnt activation in the micromechanical vibration-enhanced osteogenic response of osteoblasts. J Orthop Sci 16, 598, 2011
14. Hwang, S.J., Lublinsky, S., Seo, Y.K., Kim, I.S., and Judex, S. Extremely small-magnitude accelerations enhance bone regeneration: a preliminary study. Clin Orthop Relat Res 467, 1083, 2008
15. Lai, J.P., Wang, F.S., Hung, C.M., Wang, C.J., Huang, C.J., and Kuo, Y.R. Extracorporeal shock wave accelerates consolidation in distraction osteogenesis of the rat mandible. J Trauma 69, 1252, 2010
16. Kawamoto, K., Kim, W.C., Tsuchida, Y., Tsuji, Y., Fujioka, M., Horii, M., Mikami, Y., Tokunaga, D., and Kubo, T. Effects of alternating current electrical stimulation on lengthening callus. J Pediatr Orthop B 14, 299, 2005
17. Cakarer, S., Olgac, V., Aksakalli, N., Tang, A., and Keskin, C. Acceleration of consolidation period by thrombin peptide 508 in tibial distraction osteogenesis in rats. Br J Oral Maxillofac Surg 48, 633, 2010
18. Fujio, M., Yamamoto, A., Ando, Y., Shohara, R., Kinoshita, K., Kaneko, T., Hibi, H., and Ueda, M. Stromal cell-derived factor-1 enhances distraction osteogenesis-mediated skeletal tissue regeneration through the recruitment of endothelial precursors. Bone 49, 693, 2011
19. Yamane, K., OkanoT, Kishimoto, H., and Hagino, H. Effect of ED-71 on modeling of bone in distraction osteogenesis. Bone 24, 187, 1999
20. Namazi, H. Enhancing bone healing during distraction osteogenesis with platelet-rich plasma: a novel molecular mechanism. Injury 43, 1225, 2012
21. Shao, Z., Liu, B., Peng, Q., Liu, W., Liu, Y., Liu, R., Xu, Y., and Liu, L. Transplantation of osteoblast-like cells to the distracted callus in the rabbit mandible. Plast Reconstr Surg 119, 500, 2007
22. Xue, J., Peng, J., Yuan, M., Wang, A., Zhang, L., Liu, S., Fan, M., Wang, Y., Xu, W., Ting, K., Zhang, X., and Lu, S. NELL1 promotes high-quality bone regeneration in rat femoral distraction osteogenesis model. Bone 48, 485, 2011
23. Perrien, D.S., Nicks, K.M., Liu, L., Akel, N.S., Bacon, A.W., Skinner, R.A., Swain, F.L., Aronson, J., Suva, L.J., and Gaddy, D. Inhibin A enhances bone formation during distraction osteogenesis. J Orthop Res 30, 288, 2012
24. Song, H.R., Oh, C.W., Kyung, H.S., Park, I.H., Kim, P.T., Baek, S.H., Kim, S.J., and Lee, S.T. Injected calcium sulfate for consolidation of distraction osteogenesis in rabbit tibia. J Pediatr Orthop B 13, 170, 2004
25. Sen, C., Gunes, T., Erdem, M., Koseoglu, R.D., and Filiz, N.O. Effects of calcitonin and alendronate on distraction osteogenesis. Int Orthop 30, 272, 2006
26. Abbaspour, A., Takahashi, M., Sairyo, K., Takata, S., Yukata, K., Inui, A., and Yasui, N. Optimal increase in bone mass by continuous local infusion of alendronate during distraction osteogenesis in rabbits. Bone 44, 917, 2009
27. Kurklu, M., Yildiz, C., Kose, O., Yurttas, Y., Karacalioglu, O., Serdar, M., and Deveci, S. Effect of alpha-tocopherol on bone formation during distraction osteogenesis: a rabbit model. J Orthop Traumatol 12, 153, 2011
28. Jiang, X., Song, D., Ye, B., Wang, X., Song, G., Yang, S., and Hu, J. Effect of intermittent administration of adiponectin on bone regeneration following mandibular osteodistraction in rabbits. J Orthop Res 29, 1081, 2011
29. Claes, L., Augat, P., Schorlemmer, S., Konrads, C., Ignatius, A., and Ehrnthaller, C. Temporary distraction and compression of a diaphyseal osteotomy accelerates bone healing. J Orthop Res 6, 772, 2008
30. Cillo, J.E. Jr., Gassner, R., Koepsel, R.R., and Buckley, M.J. Growth factor and cytokine gene expression in mechanically strained human osteoblast-like cells: implications for distraction osteogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90, 147, 2000
31. Pape, H.C., Marcucio, R., Humphrey, C., Colnot, C., Knobe, M., and Harvey, E.J. Trauma-induced inflammation and fracture healing. J Orthop Trauma 24, 522, 2010
32. Urist, M.R. Bone: formation by autoinduction. Science 150, 893, 1965
33. Ducy, P., and Karsenty, G. The family of bone morphogenetic proteins. Kidney Int 57, 14, 2000
34. Sakou, T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22, 591, 1998
35. Miyazono, K., Kamiya, Y., and Morikawa, M. Bone morphogenetic protein receptors and signal transduction. J Biochem 147, 35, 2010
36. Lou J XF, Merkel, K., and Manske, P. Gene therapy: adenovirus- mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 17, 43, 1999
37. Gazzerro, E., and Canalis, E. Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7, 51, 2006
38. Tsialogiannis, E., Polyzois, I., Oak Tang, Q., Pavlou, G., Tsiridis, E., Heliotis, M., and Tsiridis, E. Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism. Expert Opin Ther Targets 13, 123, 2009
39. Rosen, V. Harnessing the parathyroid hormone, Wnt, and bone morphogenetic protein signaling cascades for successful bone tissue engineering. Tissue Eng Part B Rev 17, 475, 2011
40. Kawasaki, T., Niki, Y., Miyamoto, T., Horiuchi, K., Matsumoto, M., Aizawa, M., and Toyama, Y. The effect of timing in the administration of hepatocyte growth factor to modulate BMP-2-induced osteoblast differentiation. Biomaterials 31, 1191, 2010
41. Laflamme, C., Curt, S., and Rouabhia, M. Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation. Arch Oral Biol 55, 689, 2010
42. Israel, D.I., Nove, J., Kerns, K.M., Kaufman, R.J., Rosen, V., Cox, K.A., and Wozney, J.M. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13, 291, 1996
43. Abe, E. Function of BMPs and BMP antagonists in adult bone. Skelet Dev Remodel Health Dis Aging 1068, 41, 2006
44. Cheng, H., Jiang, W., Phillips, F.M., Haydon, R.C., Peng, Y., Zhou, L., Luu, H.H., An, N., Breyer, B., Vanichakarn, P., Szatkowski, J.P., Park, J.Y., and He, T.C. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A, 1544, 2003
45. Rauch, F., Lauzier, D., Croteau, S., Travers, R., Glorieux, F.H., and Hamdy, R. Temporal and spatial expression of bone morphogenetic protein-2, - 4, and - 7 during distraction osteogenesis in rabbits. Bone 27, 453, 2000
46. Campisi, P., Hamdy, R.C., Lauzier, D., Amako, M., Rauch, F., and Lessard, M.L. Expression of bone morphogenetic proteins during mandibular distraction osteogenesis. Plast Reconstr Surg 111, 201, 2003
47. Alam, N., St-Arnaud, R., Lauzier, D., Rosen, V., and Hamdy, R.C. Are endogenous BMPs necessary for bone healing during distraction osteogenesis? Clin Orthop Relat Res 467, 3190, 2009
48. Haque, T., Mandu-Hrit, M., Rauch, F., Lauzier, D., Tabrizian, M., and Hamdy, R.C. Immunohistochemical localization of bone morphogenetic protein-signaling Smads during long-bone distraction osteogenesis. J Histochem Cytochem 54, 407, 2006
49. Yonezawa, H., Harada, K., Ikebe, T., Shinohara, M., and Enomoto, S. Effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on bone consolidation on distraction osteogenesis: a preliminary study in rabbit mandibles. J Craniomaxillofac Surg 34, 270, 2006
50. Cheung, L.K., and Zheng, L.W. Effect of recombinant human bone morphogenetic protein-2 on mandibular distraction at different rates in an experimental model. J Craniofac Surg 17, 100, 2006
51. Mandu-Hrit, M., Haque, T., Lauzier, D., Kotsiopriftis, M., Rauch, F., Tabrizian, M., Henderson, J., and Hamdy, R.C. Early injection of OP-1 during distraction osteogenesis accelerates new bone formation in rabbits. Growth Factors 24, 172, 2006
52. Hamdy, R.C., Amako, M., Beckman, L., Kawaguchi, M., Rauch, F., Lauzier, D., and Steffen, T. Effects of osteogenic protein-1 on distraction osteogenesis in rabbits. Bone 33, 248, 2003
53. Mizumoto, Y., Moseley, T., Drews, M., Cooper, V.N., 3rd, and Reddi, A.H. Acceleration of regenerate ossification during distraction osteogenesis with recombinant human bone morphogenetic protein-7. J Bone Joint Surg Am 85-A, 124, 2003
54. Zheng, L.W., and Chenug, L.K. Effect of recombinant human bone morphogenetic protein-2 on mandibular distraction at different rates in a rabbit model. Tissue Eng 12, 3, 2006
55. Hollinger, J.O., Uludag, H., and Winn, S.R. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 31, 303, 1998
56. Bouxsein, M.L., Turek, T.G., Blake, C.A., D'Augusta, D., Li, X., Stevens, M., Seeherman, H.J., and Wozney, J.M. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am 83-A, 1219, 2001
57. Kirker-Head, C.A. Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev 15, 181, 2000
58. Wozney, J.M. Overview of bone morphogenetic proteins. Spine (Phila Pa 1976) 27, S2, 2002
59. Bishop, G.B., and Einhorn, T.A. Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31, 721, 2007
60. Rengachary, S.S. Bone morphogenetic proteins: basic concepts. Neurosurg Focus 13, e2, 2002
61. Dohin, B., Dahan-Oliel, N., Fassier, F., and Hamdy, R. Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): early experience. Clin Orthop Relat Res 467, 3230, 2009
62. Hsu, M.Y., Rovinsky, S., Penmatcha, S., Herlyn, M., and Muirhead, D. Bone morphogenetic proteins in melanoma: angel or devil? Cancer Metastasis Rev 24, 251, 2005
63. Gautschi, O.P., Frey, S.P., and Zellweger, R. Bone morphogenetic proteins in clinical applications. ANZ J Surg 77, 626, 2007
64. Lesaichot, V., Leperlier, D., Viateau, V., Richarme, D., Petite, H., and Sailhan, F. The influence of Bone Morphogenic Protein-2 on the consolidation phase in a distraction osteogenesis model. Injury 42, 1460, 2011
65. Ashinoff, R.L., Cetrulo, C.L., Jr., Galiano, R.D., Dobryansky, M., Bhatt, K.A., Ceradini, D.J., Michaels, J., 5th, McCarthy, J.G., and Gurtner, G.C. Bone morphogenic protein-2 gene therapy for mandibular distraction osteogenesis. Ann Plast Surg 52, 585, 2004
66. Haidar, Z.S., Tabrizian, M., and Hamdy, R.C. A hybrid rhOP-1 delivery system enhances new bone regeneration and consolidation in a rabbit model of distraction osteogenesis. Growth Factors 28, 44, 2010
67. Long, J., Li, P., Du, H.M., Liu, L., Zheng, X.H., Lin, Y.F., Wang, H., Jing, W., Tang, W., Chen, W.H., and Tian, W.D. Effects of bone morphogenetic protein 2 gene therapy on new bone formation during mandibular distraction osteogenesis at rapid rate in rabbits. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112, 50, 2011
68. Yang, J.H., Kim, H.J., Kim, S.E., Yun, Y.P., Bae, J.H., Kim, S.J., Choi, K.H., and Song, H.R. The effect of bone morphogenic protein-2-coated tri-calcium phosphate/ hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis. Cytotherapy 3, 315, 2012
69. Zhang, W.B., Zhang, L.W., Chua, D.T., and Cheung, L.K. Treatment of irradiated mandibles with mesenchymal stem cells transfected with bone morphogenetic protein 2/7. J Oral Maxillofac Surg 70, 1711, 2012
70. Sailhan, F., Gleyzolle, B., Parot, R., Guerini, H., and Viguier, E. Rh-BMP-2 in distraction osteogenesis: dose effect and premature consolidation. Injury 41, 680, 2010
71. Zhu, S., Song, D., Jiang, X., Zhou, H., and Hu, J. Combined effects of recombinant human BMP-2 and Nell-1 on bone regeneration in rapid distraction osteogenesis of rabbit tibia. Injury 42, 1467, 2011
72. Kloen, P., Lauzier, D., and Hamdy, R.C. Co-expression of BMPs and BMP-inhibitors in human fractures and nonunions. Bone 51, 59, 2012
73. Takayama, K., Suzuki, A., Manaka, T., Taguchi, S., Hashimoto, Y., Imai, Y., Wakitani, S., and Takaoka, K. RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro. J Bone Miner Metab 27, 402, 2009
74. Winkler, D.G., Yu, C., Geoghegan, J.C., Ojala, E.W., Skonier, J.E., Shpektor, D., Sutherland, M.K., and Latham, J.A. Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex. J Biol Chem 279, 36293, 2004
75. Kwong, F.N., Richardson, S.M., and Evans, C.H. Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells. Arthritis Res Ther 10, R65, 2008
76. Li, X., Ominsky, M.S., Niu, Q.T., Sun, N., Daugherty, B., D'Agostin, D., Kurahara, C., Gao, Y., Cao, J., Gong, J., Asuncion, F., Barrero, M., Warmington, K., Dwyer, D., Stolina, M., Morony, S., Sarosi, I., Kostenuik, P.J., Lacey, D.L., Simonet, W.S., Ke, H.Z., and Paszty, C. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23, 860, 2008
77. Ku, M., Howard, S., Ni, W., Lagna, G., and Hata, A. OAZ regulates bone morphogenetic protein signaling through Smad6 activation. J Biol Chem 281, 5277, 2006
78. Zhao, M., Qiao, M., Harris, S.E., Oyajobi, B.O., Mundy, G.R., and Chen, D. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem 279, 12854, 2004
79. Haque, T., Hamade, F., Alam, N., Kotsiopriftis, M., Lauzier, D., St-Arnaud, R., and Hamdy, R.C. Characterizing the BMP pathway in a wild type mouse model of distraction osteogenesis. Bone 42, 1144, 2008
80. Mehrara, B.J., Rowe, N.M., Steinbrech, D.S., Dudziak, M.E., Saadeh, P.B., McCarthy, J.G., Gittes, G.K., and Longaker, M.T. Rat mandibular distraction osteogenesis: II. Molecular analysis of transforming growth factor beta-1 and osteocalcin gene expression. Plast Reconstr Surg 103, 536, 1999
81. Joyce, M.E., Roberts, A.B., Sporn, M.B., and Bolander, M.E. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 110, 2195, 1990
82. Yeung, H.Y., Lee, K.M., Fung, K.P., and Leung, K.S. Sustained expression of transforming growth factor-beta1 by distraction during distraction osteogenesis. Life Sci 71, 67, 2002
83. Mundy, G.R., and Bonewald, L.F. Role of TGF beta in bone remodeling. Ann N Y Acad Sci 593, 91, 1990
84. Nielsen, H.M., Andreaseen, T.T., Ledet, T., and Oxlund, H. Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop Scand 65, 37, 1994
85. Lind, M., Schumacker, B., Søballe, K., Keller, J., Melsen, F., and Bu? nger, C. Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthop Scand 64, 553, 1993
86. Peterson, D.R., Glancy, T.P., and Bacon-Clarke, R. A study ofdelivery timing and duration on the transforming growth factor beta 1 induced healing ofcritical size long bone defects. J Bone Miner Res 12, S304, 1997
87. Rauch, F., Lauzier, D., Travers, R., Glorieux, F., and Hamdy, R. Effects of locally applied transforming growth factor-beta1 on distraction osteogenesis in a rabbit limblengthening model. Bone 26, 619, 2000
88. Ozkan, K., Eralp, L., Kocaoglu, M., Ahishali, B., Bilgic, B., Mutlu, Z., Turker, M., Ozkan, F.U., Sahin, K., and Guven, M. The effect of transforming growth factor beta1 (TGFbeta1) on the regenerate bone in distraction osteogenesis. Growth Factors 25, 101, 2007
89. Yakar, S., Courtland, H.W., and Clemmons, D. IGF-1 and bone: new discoveries from mouse models. J Bone Miner Res 25, 2543, 2010
90. Nakasaki, M., Yoshioka, K., Miyamoto, Y., Sasaki, T., Yoshikawa, H., and Itoh, K. IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone 43, 868, 2008
91. Govoni, K.E., Wergedal, J.E., Florin, L., Angel, P., Baylink, D.J., and Mohan, S. Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion. Endocrinology 148, 5706, 2007
92. Zhang, M., Xuan, S., Bouxsein, M.L., von Stechow, D., Akeno, N., Faugere, M.C., Malluche, H., Zhao, G., Rosen, C.J., Efstratiadis, A., and Clemens, T.L. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277, 44005, 2002
93. Schumacher, B., Albrechtsen, J., Keller, J., Flyvbjerg, A., and Hvid, I. Periosteal insulin-like growth factor I and bone formation. Changes during tibial lengthening in rabbits. Acta Orthop Scand 67, 237, 1996
94. Eingartner, C., Coerper, S., Fritz, J., Gaissmaier, C., Koveker, G., and Weise, K. Growth factors in distraction osteogenesis. Immuno-histological pattern of TGF-beta1 and IGF-I in human callus induced by distraction osteogenesis. Int Orthop 23, 253, 1999
95. Stewart, K.J., Weyand, B., van't Hof, R.J., White, S.A., Lvoff, G.O., Maffulli, N., and Poole, M.D. A quantitative analysis of the effect of insulin-like growth factor-1 infusion during mandibular distraction osteogenesis in rabbits. Br J Plast Surg 52, 343, 1999
96. Bernstein, A., Mayr, H.O., and Hube, R. Can bone healing in distraction osteogenesis be accelerated by local application of IGF-1 and TGF-beta1? J Biomed Mater Res B Appl Biomater 92, 215, 2010
97. Yun, Y.R., Won, J.E., Jeon, E., Lee, S., Kang, W., Jo, H., Jang, J.H., Shin, U.S., and Kim, H.W. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 2010, 218142, 2010
98. Rifkin, D.B., and Moscatelli, D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109, 1, 1989
99. Nakamura, K., Kurokawa, T., Kato, T., Okazaki, H., Mamada, K., Hanada, K., Hiyama, Y., Aoyama, I., Nakamura, T., and Tamura, M. Local application of basic fibroblast growth factor into the bone increases bone mass at the applied site in rabbits. Arch Orthop Trauma Surg 115, 344, 1996
100. Nakamura, K., Kawaguchi, H., Aoyama, I., Hanada, K., Hiyama, Y., Awa, T., Tamura, M., and Kurokawa, T. Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits. J Orthop Res 15, 307, 1997
101. Kato, T., Kawaguchi, H., Hanada, K., Aoyama, I., Hiyama, Y., Nakamura, T., Kuzutani, K., Tamura, M., Kurokawa, T., and Nakamura, K. Single local injection of recombinantfibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J Orthop Res 16, 654, 1998
102. Kawaguchi, H., Oka, H., Jingushi, S., Izumi, T., Fukunaga, M., Sato, K., Matsushita, T., Nakamura, K.; TESK Group. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: a randomized, placebocontrolled trial. J Bone Miner Res 25, 2735, 2010
103. Hu, J., Zou, S., Li, J., Chen, Y., Wang, D., and Gao, Z. Temporospatial expression of vascular endothelial growth factor and basic fibroblast growth factor during mandibular distraction osteogenesis. J Craniomaxillofac Surg 31, 238, 2003
104. Yeung, H.Y., Lee, S.K., Fung, K.P., and Leung, K.S. Expression of basic fibroblast growth factor during distraction osteogenesis. Clin Orthop Relat Res 385, 219, 2001
105. Okazaki, H., Kurokawa, T., Nakamura, K., Matsushita, T., Mamada, K., and Kawaguchi, H. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits. Calcif Tissue Int 64, 542, 1999
106. Higuchi, Y., Kabasawa, Y., Sato, M., Kikuchi, T., Aoki, K., Ohya, K., Maruoka, Y., and Omura, K. Effect of recombinant human fibroblast growth factor-2 on bone formation in rabbit mandibular distraction models using beta-tricalcium phosphate. Congenit Anom (Kyoto) 50, 95, 2010
107. Ferrara, N., Gerber, H.P., and LeCouter, J. The biology of VEGF and its receptors. Nat Med 9, 669, 2003
108. Dai, J., and Rabie, A.B. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J Dent Res 86, 937, 2007
109. Ochman, S., Frey, S., Raschke, M.J., Deventer, J.N., and Meffert, R.H. Local application of VEGF compensates callus deficiency after acute soft tissue trauma - results using a limb-shortening distraction procedure in rabbit tibia. J Orthop Res 29, 1093, 2011
110. Kleinheinz, J., Stratmann, U., Joos, U., and Wiesmann, H.P. VEGF-activated angiogenesis during bone regeneration. J Oral Maxillofac Surg 63, 1310, 2005
111. Pacicca, D.M., Patel, N., Lee, C., Salisbury, K., Lehmann, W., Carvalho, R., Gerstenfeld, L.C., and Einhorn, T.A. Expression of angiogenic factors during distraction osteogenesis. Bone 33, 889, 2003
112. Warren, S.M., Mehrara, B.J., Steinbrech, D.S., Paccione, M.F., Greenwald, J.A., Spector, J.A., and Longaker, M.T. Rat mandibular distraction osteogenesis: part III. Gradual distraction versus acute lengthening. Plast Reconstr Surg 107, 441, 2001
113. Carvalho, R.S., Einhorn, T., Lehmann, W., Edgar, C., Al- Yamani, A., Apazidis, A., Pacicca, D., Clemens, T.L., and Gerstenfeld, L.C. The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone 34, 849, 2004
114. Ohashi, S., Ohinshi, I., Kageyama, T., Fukuda, S., Tsuchiya, A., Imai, K., Matsuyama, J., and Nakamura, K. Effect of vascularity on canine distracted tibial callus consolidation. Clin Orthop Relat Res 438, 253, 2005
115. Schiller, J.R., Moore, D.C., and Ehrlich, M.G. Increased lengthening rate decreases expression of fibroblast growth factor 2, platelet-derived growth factor, vascular endothelial growth factor, and CD31 in a rat model of distraction osteogenesis. J Pediatr Orthop 27, 961, 2007
116. Eckardt, H., Bundgaard, K.G., Christensen, K.S., Lind, M., Hansen, E.S., and Hvid, I. Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis. J Orthop Res 21, 335, 2003
117. Wan, C., Gilbert, S.R., Wang, Y., Cao, X., Shen, X., Ramaswamy, G., Jacobsen, K.A., Alaql, Z.S., Eberhardt, A.W., Gerstenfeld, L.C., Einhorn, T.A., Deng, L., and Clemens, T.L. Activation of the hypoxia-inducible factor- 1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 105, 686, 2008
118. Hollinger, J.O., Hart, C.E., Hirsch, S.N., Lynch, S., and Friedlaender, G.E. Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am 90, 48, 2008
119. Seifert, R.A., Hart, C.E., Phillips, P.E., Forstrom, J.W., Ross, R., Murray, M.J., and Bowen-Pope, D.F. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 264, 8771, 1989
120. Hollinger, J.O., Onikepe, A.O., MacKrell, J., Einhorn, T., Bradica, G., Lynch, S., and Hart, C.E. Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res 26, 83, 2008
121. Nash, T.J., Howlett, C.R., Martin, C., Steele, J., Johnson, K.A., and Hicklin, D.J. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 15, 203, 1994
122. Moore, D.C., Ehrlich, M.G., McAllister, S.C., Machan, J.T., Hart, C.E., Voigt, C., Lesieur-Brooks, A.M., and Weber, E.W. Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis. J Bone Joint Surg Am 91, 1973, 2009
123. Solchaga, L.A., Hee, C.K., Roach, S., and Snel, L.B. Safety of recombinant human platelet-derived growth factor-BB in Augment Bone Graft. J Tissue Eng 3, 2041731412442668, 2012
124. Malhotra, A., Pelletier, M.H., Yu, Y., and Walsh, W.R. Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. Arch Orthop Trauma Surg 133, 153, 2013
125. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85, 638, 1998
126. Kanno, T., Takahashi, T., Tsujisawa, T., Ariyoshi, W., and Nishihara, T. Platelet-rich plasma enhances human osteoblast- like cell proliferation and differentiation. J Oral Maxillofac Surg 63, 362, 2005
127. Weibrich, G., Kleis, W.K., Hafner, G., and Hitzler, W.E. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30, 97, 2002
128. Marx, R.E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62, 489, 2004
129. Cervelli, V., Gentile, P., Scioli, M.G., Grimaldi, M., Casciani, C.U., Spagnoli, L.G., and Orlandi, A. Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Methods 15, 625, 2009
130. Hokugo, A., Ozeki, M., Kawakami, O., Sugimoto, K., Mushimoto, K., Morita, S., and Tabata, Y. Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng 11, 1224, 2005
131. de Vos, R.J., van Veldhoven, P.L., Moen, M.H., Weir, A., Tol, J.L., and Maffulli, N. Autologous growth factor injections in chronic tendinopathy: a systematic review. Br Med Bull 95, 63, 2010
132. Liu, H.Y., Wu, A.T., Tsai, C.Y., Chou, K.R., Zeng, R., Wang, M.F., Chang, W.C., Hwang, S.M., Su, C.H., and Deng, W.P. The balance between adipogenesis and osteogenesis in bone regeneration by platelet-rich plasma for age-related osteoporosis. Biomaterials 32, 6773, 2011
133. Kawasumi, M., Kitoh, H., Siwicka, K.A., and Ishiguro, N. The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of bone. J Bone Joint Surg Br 90, 966, 2008
134. Choi, B.H., Zhu, S.J., Kim, B.Y., Huh, J.Y., Lee, S.H., and Jung, J.H. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg 34, 420, 2005
135. Kitoh, H., Kitakoji, T., Tsuchiya, H., Katoh, M., and Ishiguro, N. Distraction osteogenesis of the lower extremity in patients with achondroplasia/hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma. J Pediatr Orthop B 27, 629, 2007
136. Latalski, M., Elbatrawy, Y., Thabet, A.M., Gregosiewicz, A., Raganowicz, T., and Fatyga, M. Enhancing bone healing during distraction osteogenesis with platelet-rich plasma. Injury 42, 821, 2011
137. Boerckel, J.D., Kolambkar, Y.M., Dupont, K.M., Uhrig, B.A., Phelps, E.A., Stevens, H.Y., Garci'a, A.J., and Guldberg, R.E. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 32, 5241, 2011
138. La, W.G., Kang, S.W., Yang, H.S., Bhang, S.H., Lee, S.H., Park, J.H., and Kim, B.S. The efficacy of bone morphogenetic protein-2 depends on its mode of delivery. Artif Organs 34, 1150, 2010
139. Haidar, Z.S., Hamdy, R.C., and Tabrizian, M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnol Lett 31, 1817, 2009
140. Haidar, Z.S., Hamdy, R.C., and Tabrizian, M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol Lett 31, 1825, 2009
141. Yamamoto, M., Takahashi, Y., and Tabata, Y. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 12, 1305, 2006
142. Barnes, B., Boden, S.D., Louis-Ugbo, J., Tomak, P.R., Park, J.S., Park, M.S., and Minamide, A. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates. Spine (Phila Pa 1976) 30, 1127, 2005
143. Saito, N., Murakami, N., Takahashi, J., Horiuchi, H., Ota, H., Kato, H., Okada, T., Nozaki, K., and Takaoka, K. Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins. Adv Drug Deliv Rev 57, 1037, 2005
144. Wei, G., Jin, Q., Giannobile, W.V., and Ma, P.X. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28, 2087, 2007
145. Zhang, Z., and Feng, S.S. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 27, 4025, 2006
146. Dong, Y., and Feng, S.S. Methoxy poly(ethylene glycol)- poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25, 2843, 2004
147. Gref, R., Minamatake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V., and Langer, R. Biodegradable long-circulating polymeric nanospheres. Science 263, 1600, 1994
148. Jeon, O., Song, S.J., Yang, H.S., Bhang, S.H., Kang, S.W., Sung, M.A., Lee, J.H., and Kim, B.S. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun 369, 774, 2008
149. Yilgor, P., Hasrici, N., and Hasirci, V. Sequential BMP-2/ BMP-7 delivery from polyester nanocapsules. J Biomed Mater Res A 93, 528, 2010
150. Haidar, Z.S., Hamdy, R.C., and Tabrizian, M. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials 9, 1207, 2008
151. Haidar, Z.S., Azari, F., Hamdy, R.C., and Tabrizian, M. Modulated release of OP-1 and enhanced preosteoblast differentiation using a core-shell nanoparticulate system. J Biomed Mater Res A 91, 919, 2009
152. Haidar, Z.S., Hamdy, R.C., and Tabrizian, M. Biocompatibility and safety of a hybrid core-shell nanoparticulate OP- 1 delivery system intramuscularly administered in rats. Biomaterials 31, 2746, 2010
153. Yeh, L.C., and Lee, J.C. Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-I gene enhanced osteoblastic cell differentiation. Biochim Biophys Acta 1763, 57, 2006
154. Vonau, R.L., Bostrom, M.P., Aspenberg, P., and Sams, A.E. Combination of growth factors inhibits bone ingrowth in the bone harvest chamber. Clin Orthop Relat Res 386, 243, 2001
155. Chen, F.M., Zhang, M., and Wu, Z.F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 31, 6279, 2010
156. Liu, J., Xu, L., Li, Y., and Ma, J. Temporally controlled multiple-gene delivery in scaffolds: a promising strategy to enhance bone regeneration. Med Hypotheses 76, 173, 2011